Early taxane exposure and neurotoxicity in breast cancer patients
Despite the absence of effective treatments to prevent paclitaxel-induced neurotoxicity, symptoms are managed through dosage reduction, delay, or treatment interruption. Future research should focus on identifying neuroprotective measures to avoid an irreversible decline in the quality of life for breast cancer survivors.
Authors
- Andrea Pretta (ORCID: https://orcid.org/0000-0002-0262-9270)
- Eleonora Lai (ORCID: https://orcid.org/0000-0001-7726-1864)
- Marta Pozzari
- Enrico Palmas
- Mario Scartozzi (ORCID: https://orcid.org/0000-0001-5977-5546)
- Stefano Mariani (ORCID: https://orcid.org/0000-0001-8921-8150)
- Dario Spanu
- Pina Ziranu (ORCID: https://orcid.org/0000-0002-5659-7366)
- Salvatore Sardo
- Clelia Donisi
- Francesco Atzori (ORCID: https://orcid.org/0000-0002-8211-0363)
- Gabriele Finco (ORCID: https://orcid.org/0000-0002-3059-9865)
- Mariele Dessì
- Sara Murgia
- Clelia Madeddu (ORCID: https://orcid.org/0000-0001-8940-6987)
- Erika Cimbro
- Claudia Codipietro
- Francesca Semonella
- Giorgio Saba
- Giorgia Sanna
Institutions
- University of Cagliari (IT)
Publication Details
- Journal
- Supportive Care in Cancer
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1007/s00520-024-08908-2
- Citations
- 3
- Primary Topic
- Cancer Treatment and Pharmacology
- Type
- article
- Field-Weighted Citation Impact
- 0.85
Funders
- Università degli Studi di Cagliari